| | | | Index Performance | | Index | Sensex | Nifty | | Open | 14,979.96 | 4,522.00 | | High | 15,088.03 | 4,522.55 | | Low | 14,645.31 | 4,369.80 | | Today's Cls | 14,889.25 | 4,449.80 | | Prev Cls | 15,066.10 | 4,500.95 | | Change | -176.85 | -51.15 | | % Change | -1.17 | -1.14 | | | | Market Indicators | | Top Movers (Group A) | | Company | Price
(Rs) | %
chg | | Gainers | | Nagarjuna Fertilizers | 39.25 | 8.15 | | Ranbaxy Lab | 526.40 | 6.53 | | Divi's Lab | 1,454.85 | 4.76 | | Chambal Fertilisers | 74.70 | 4.69 | | Sun TV | 334.65 | 4.59 | | Losers | | Essar Shipping | 119.30 | -7.50 | | Canara Bank | 200.30 | -6.99 | | Tech Mahindra | 794.45 | -6.99 | | ABG Shipyard | 428.55 | -6.98 | | Great Offshore | 634.85 | -6.97 | | | Market Statistics | | - | BSE | NSE | | Advances | 964 | 434 | | Declines | 1,667 | 763 | | Unchanged | 68 | 35 | | Volume(Nos) | 25.83cr | 52.73cr | | | | | | Market Commentary | | | Sensex erases its lows but sheds 96 points at close | | Across-the-board selling saw the Sensex slip below 15,600 mark, but selective buying towards the close enabled the index make up for the losses. | | Weak global cues and negative breadth in yesterday's trades, led the market open at a lower today. The Sensex was down 86 points at the open and | 
| | | remained subdued, as investors booked profits after the recent gains. IT, banking, consumer durables and reality stocks took the major beating, but healthcare stocks bucked the trend on gains in Cadila Healthcare and Ranbaxy Laboratories. The index faltered under selling pressure by afternoon and slipped to the day's low of 14,645. While the market fluctuated sharply thereafter, firm bullish sentiment and strong buying in heavyweights and health care stocks in the late trades helped the Sensex erase most of its losses. The Sensex finally ended the session by shedding 1.17% or 177 points at 14,889. Nifty slipped by 51 points at 4,450. | | | Movers & Shakers | - ABG Shipyard moved down despite recommending a dividend for its shareholders.
- Diamond Cables slipped inspite of the report that the company has been successful to further raise the working capital limit of Rs60 crore from Axis Bank under the consortium arrangement with the Bank of India and ICICI Bank.
| | | |
The market breadth was negative. Of the 2,699 stocks traded on the BSE, 1,667 stocks declined, 964 stocks advanced and 68 stocks ended unchanged. Most of the sectoral indices ended in red. The BSE IT index dropped 2.75% at 4,284 followed by the BSE Bankex index (down 2.43% at 6,740), the BSE CD index (down 2.37% at 3,841) and the BSE Realty index (down 2.11% at 5,631). However, the BSE HC index gained 2.16% at 4,412 and the BSE Oil & Gas index (up 0.15% at 9.691).
Heavyweights led the fall in the Sensex. HDFC slipped by 4.79% at Rs2,064, ONGC slumped by 4.74% at Rs872.60, HDFC Bank shed 4.46% at Rs1,118, Tata Consultancy Services lost 3.89% at Rs867.20, Jaiprakash Associates was down 3.54% at Rs173.10 and Infosys tumbled by 2.89% at Rs1,795.35. Among the gainers Ranbaxy Laboratories jumped 6.53% at Rs560.75, Cipla gained 2.13% at Rs211.05, Reliance Industries soared 1.68% at Rs2,199, Hindustan Unilever rose by 1.57% at Rs234.40 and Maruti Suzuki India was up 0.76% at Rs741.50, while ACC, BHEL, Hindalco and Ambuja Cements ended with modest gains.
Over 1.85 crore IFCI shares changed hands on the BSE followed by Reliance Petroleum(1.36 crore shares), Ispat Industries (1.34 crore shares), Reliance Natural Resources (1.31 crore shares) and Spice Telecommunications (1.00 crore shares).
Reliance Industries registered a turnover of Rs281 crore on the BSE followed by Reliance Capital (Rs261 crore), Reliance Petroleum (Rs231 crore), Ranbaxy Laboratories (Rs213 crore) and Anu’s Laboratories (Rs167 crore).
| | | | | | | | European Indices at 16:13 IST on 10-06-2008 | | | | Index | Level | Change (pts) | Change (%) | | FTSE 100 Index | 5846.70 | -30.90 | -0.53 | | CAC 40 Index | 4763.44 | -35.94 | -0.75 | | DAX Index | 6762.45 | -53.18 | -0.78 | | | | | | | | | | | Asian Indices at close on 10-06-2008 | | | | Index | Level | Change (pts) | Change (%) | | Nikkei 225 | 14021.17 | -160.21 | -1.13 | | Hang Seng Index | 23375.52 | -1026.66 | -4.21 | | Kospi Index | 1774.38 | -34.58 | -1.91 | | Straits Times Index | 3033.05 | -50.97 | -1.65 | | Jakarta Composite Index | 2373.82 | -36.26 | -1.50 | | | | | | | | To know more about our products and services, click here. | | | | | | | “This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction.
Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN.” | To unsubscribe write to myaccount@sharekhan.com | |
No comments:
Post a Comment